Display options
Cite
Menezes C, Carvalho R, Teixeira C, et al. Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab. Case Rep Ophthalmol. 2015;6(2):170-5doi: 10.1159/000431353.
Menezes, C., Carvalho, R., Teixeira, C., Lemos, J. A., Gonçalves, R., Coelho, P., & Lima, A. (2015). Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab. Case reports in ophthalmology, 6(2), 170-5. https://doi.org/10.1159/000431353
Menezes, Carlos, et al. "Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab." Case reports in ophthalmology vol. 6,2 (2015): 170-5. doi: https://doi.org/10.1159/000431353
Menezes C, Carvalho R, Teixeira C, Lemos JA, Gonçalves R, Coelho P, Lima A. Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab. Case Rep Ophthalmol. 2015 Jun 02;6(2):170-5. doi: 10.1159/000431353. eCollection 2015. PMID: 26120315; PMCID: PMC4478313.
Copy Download .nbib Format: NLM
Share it on

Case Rep Ophthalmol. 2015 Jun 02;6(2):170-5. doi: 10.1159/000431353. eCollection 2015.

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab.

Case reports in ophthalmology

Carlos Menezes, Rui Carvalho, Carla Teixeira, José Alberto Lemos, Rita Gonçalves, Pedro Coelho, André Lima

Affiliations

  1. Department of Ophthalmology, Pedro Hispano Hospital, Matosinhos, Portugal.

PMID: 26120315 PMCID: PMC4478313 DOI: 10.1159/000431353

Abstract

PURPOSE: We report a case of a foveal macroaneurysm with long-standing macular edema in a rare location, successfully treated with intravitreal ranibizumab.

METHODS: We report the case of a 52-year-old man with left eye long-term visual loss due to macular edema caused by a retinal macroaneurysm, localized about 400 μm from the center of the fovea, and its response to 6 monthly ranibizumab intravitreal injections. His best-corrected visual acuity and morphological data evaluated by optical coherence tomography and fluorescein angiography are presented.

RESULTS: His best-corrected visual acuity improved from 1/10 to 3/10 after the 3rd injection, and from 1/10 to 4/10 after the 6th one. The central retinal thickness was evaluated by optical coherence tomography and improved from 310 to 233 μm, with the resolution of both the associated serous detachments and the cystoid macular edema; an almost complete reabsorption of the hard exudates at the end of the treatment was also observed. The macroaneurysm lumen almost obliterated after the 3rd injection and completely collapsed at the end of treatment.

CONCLUSIONS: Intravitreal ranibizumab may be effective in the treatment of long-standing macular edema associated with foveal macroaneurysms. To the best of our knowledge, this is the first report of a retinal macroaneurysm located so close to the foveal avascular zone.

Keywords: Exudative retinal macroaneurysm; Fovea; Intravitreal ranibizumab

References

  1. Eye (Lond). 2009 Feb;23(2):493-4 - PubMed
  2. Acta Ophthalmol. 2010 Nov;88(7):e284 - PubMed
  3. Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1667-70 - PubMed
  4. Clin Exp Optom. 2015 Mar;98(2):117-21 - PubMed
  5. Graefes Arch Clin Exp Ophthalmol. 2015 Apr;253(4):537-41 - PubMed
  6. Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1267-8 - PubMed
  7. Retina. 2012 May;32(5):990-5 - PubMed
  8. Klin Monbl Augenheilkd. 2013 Apr;230(4):392-5 - PubMed
  9. Case Rep Ophthalmol. 2011 Sep;2(3):387-91 - PubMed
  10. Eye (Lond). 2006 Sep;20(9):1011-20 - PubMed
  11. Am J Ophthalmol. 2013 Feb;155(2):287-294.e1 - PubMed
  12. Acta Ophthalmol. 2014 Mar;92(2):101-4 - PubMed

Publication Types